Paradigm Biopharmaceuticals is working to transform treatment for osteoarthritis In 2022, the global market for osteoarthritis therapeutics was valued at $8.28 billion Phase 2 trials of iPPS into ...

Valuation wise, Paradigm Biopharmaceuticals (ASX:PAR) is what Winston Churchill referred to as a riddle wrapped in a mystery ...

Dropless cataract surgery eliminates postoperative eye drops, enhancing patient adherence and reducing complications like infection and inflammation. Intracameral drug delivery during surgery offers ...

Semaglutide medications — such as Ozempic, the popular diabetes medication — have been linked to a reduced risk of Alzheimer’s disease for certain groups, a new study finds.

The concept of Ignatian pedagogy derives from the underlying principles, values, and actions realized in the Spiritual Exercises of St. Ignatius of Loyola, founder of the Jesuits. During the Exercises ...

Positive results for Intellia Therapeutics, Inc.'s NTLA-2002 in treating HAE patients. Stock price dips, but the program ...

Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across 150 countries. Our technologies and therapies treat 70 health ...

For more information about the DIAMOND program commitee members, please visit oculis.com.

But victory is not without its costs. “The road ahead is filled with dangers and pain. The unspeakable fear and agony of the remaining hostages and their families hangs heavy. The Iranian ...

A group of 17 European countries has called for a "paradigm shift" in migration policy to ensure asylum seekers whose applications have been declined are effectively and speedily sent back to ...

Paradigm on Monday said it was confident of ... “But we know our mechanisms of action stands up for pain reduction and improving the joint and we have a huge amount of data to back that up.” ...